Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China
· Delayed Price · Currency is CNY 20.54
+0.35 (1.73%)
At close: Mar 10, 2026
SHE:301246 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2020 - 2016 |
| Cash & Equivalents | 196.89 | 745.59 | 421.86 | 395.19 | 120.43 | 264.76 | Upgrade
|
| Short-Term Investments | - | 379.25 | 292.31 | 90 | - | - | Upgrade
|
| Trading Asset Securities | 1,171 | 900.32 | 1,466 | - | - | 3 | Upgrade
|
| Cash & Short-Term Investments | 1,368 | 2,025 | 2,180 | 485.19 | 120.43 | 267.76 | Upgrade
|
| Cash Growth | -18.88% | -7.10% | 349.31% | 302.89% | -55.02% | 35.06% | Upgrade
|
| Accounts Receivable | 666.45 | 559.44 | 602.64 | 660.21 | 458.16 | 308.66 | Upgrade
|
| Other Receivables | 90.76 | 79.89 | 141.67 | 87.6 | 45.85 | 0.99 | Upgrade
|
| Receivables | 757.2 | 639.33 | 744.3 | 747.8 | 504.01 | 309.65 | Upgrade
|
| Inventory | 287.51 | 270.53 | 191.51 | 352.95 | 384.48 | 343.46 | Upgrade
|
| Other Current Assets | 725.93 | 111.34 | 86.43 | 78.98 | 20.72 | 19.84 | Upgrade
|
| Total Current Assets | 3,139 | 3,046 | 3,202 | 1,665 | 1,030 | 940.71 | Upgrade
|
| Property, Plant & Equipment | 2,277 | 2,292 | 1,910 | 1,620 | 891.27 | 592.85 | Upgrade
|
| Long-Term Investments | 186.69 | 203.64 | 228.08 | 335.12 | 242.35 | 97.24 | Upgrade
|
| Goodwill | - | - | - | - | - | 6.5 | Upgrade
|
| Other Intangible Assets | 181.24 | 181.89 | 183.06 | 173.62 | 194.15 | 84.12 | Upgrade
|
| Long-Term Deferred Tax Assets | 17.81 | 17.26 | 17.56 | 21.22 | 17.72 | 14.54 | Upgrade
|
| Long-Term Deferred Charges | 3.46 | 5.52 | 5.95 | 6.86 | 11.98 | 10.74 | Upgrade
|
| Other Long-Term Assets | 97.16 | 78.06 | 103.9 | 53.27 | 45.14 | 13.82 | Upgrade
|
| Total Assets | 5,902 | 5,825 | 5,651 | 3,875 | 2,432 | 1,761 | Upgrade
|
| Accounts Payable | 620.71 | 777.27 | 636.79 | 934.95 | 340.92 | 155.08 | Upgrade
|
| Accrued Expenses | 12.51 | 55.28 | 57.54 | 65.7 | 57.98 | 43.21 | Upgrade
|
| Short-Term Debt | 163.1 | 59.32 | - | 17.64 | 20.1 | 149.26 | Upgrade
|
| Current Portion of Long-Term Debt | 90.53 | 77.01 | 65.9 | 66.09 | 2.84 | - | Upgrade
|
| Current Portion of Leases | - | 0.74 | 0.6 | 0.56 | 0.53 | 0.74 | Upgrade
|
| Current Income Taxes Payable | 4.83 | 3.56 | 1.15 | 38.29 | 45.65 | 39.3 | Upgrade
|
| Current Unearned Revenue | 15.53 | 13.87 | 19.8 | 31.01 | 29.66 | 13.93 | Upgrade
|
| Other Current Liabilities | 170.41 | 148.94 | 133.04 | 165.66 | 120.05 | 100.93 | Upgrade
|
| Total Current Liabilities | 1,078 | 1,136 | 914.83 | 1,320 | 617.73 | 502.45 | Upgrade
|
| Long-Term Debt | 389.55 | 230.36 | 276.12 | 341.67 | 47.22 | - | Upgrade
|
| Long-Term Leases | 7.06 | 7.16 | 6.9 | 8.19 | 8.23 | 8.12 | Upgrade
|
| Long-Term Unearned Revenue | 69.91 | 68.64 | 71.55 | 70.45 | 60.8 | 44.79 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 21.77 | 21.62 | 21.54 | 21.31 | 20.3 | 20.9 | Upgrade
|
| Total Liabilities | 1,566 | 1,464 | 1,291 | 1,762 | 754.27 | 576.27 | Upgrade
|
| Common Stock | 400.01 | 400.01 | 400.01 | 352.75 | 352.75 | 352.75 | Upgrade
|
| Additional Paid-In Capital | 2,172 | 2,172 | 2,172 | 22.15 | 20.62 | 20.62 | Upgrade
|
| Retained Earnings | 1,805 | 1,818 | 1,786 | 1,739 | 1,304 | 810.3 | Upgrade
|
| Treasury Stock | -47.15 | -32.8 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 5.36 | 3.37 | 1.89 | 0 | 0.46 | 0.57 | Upgrade
|
| Total Common Equity | 4,335 | 4,361 | 4,360 | 2,114 | 1,678 | 1,184 | Upgrade
|
| Minority Interest | 0.45 | 0.47 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 4,336 | 4,361 | 4,360 | 2,114 | 1,678 | 1,184 | Upgrade
|
| Total Liabilities & Equity | 5,902 | 5,825 | 5,651 | 3,875 | 2,432 | 1,761 | Upgrade
|
| Total Debt | 650.23 | 374.59 | 349.51 | 434.14 | 78.92 | 158.12 | Upgrade
|
| Net Cash (Debt) | 717.81 | 1,651 | 1,831 | 51.05 | 41.51 | 109.64 | Upgrade
|
| Net Cash Growth | -45.50% | -9.83% | 3485.91% | 22.99% | -62.14% | - | Upgrade
|
| Net Cash Per Share | 1.82 | 4.14 | 4.72 | 0.14 | 0.12 | 0.31 | Upgrade
|
| Filing Date Shares Outstanding | 396.81 | 396.81 | 399.9 | 400.01 | 352.75 | 346.7 | Upgrade
|
| Total Common Shares Outstanding | 396.81 | 397.89 | 400.01 | 352.75 | 352.75 | 346.7 | Upgrade
|
| Working Capital | 2,061 | 1,910 | 2,287 | 345.02 | 411.91 | 438.26 | Upgrade
|
| Book Value Per Share | 10.93 | 10.96 | 10.90 | 5.99 | 4.76 | 3.42 | Upgrade
|
| Tangible Book Value | 4,154 | 4,179 | 4,177 | 1,940 | 1,484 | 1,094 | Upgrade
|
| Tangible Book Value Per Share | 10.47 | 10.50 | 10.44 | 5.50 | 4.21 | 3.15 | Upgrade
|
| Buildings | - | 833.02 | 719.62 | 395.96 | 329.31 | 316.78 | Upgrade
|
| Machinery | - | 1,649 | 1,470 | 782.58 | 657 | 567.68 | Upgrade
|
| Construction In Progress | - | 630.57 | 375.86 | 946.39 | 334.11 | 67.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.